Loading…
Teladoc Health, Inc. is projected to rise to $13.28 by 2027, a +43% move from its current price of $9.28. TDOC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $9.03 | $9.29 | $9.56 | +0.11% |
| Jul 14 | $8.93 | $9.30 | $9.69 | +0.23% |
| Jul 15 | $8.86 | $9.31 | $9.79 | +0.34% |
| Jul 16 | $8.80 | $9.32 | $9.88 | +0.45% |
| Jul 17 | $8.75 | $9.33 | $9.96 | +0.57% |
| Jul 18 | $8.70 | $9.34 | $10.03 | +0.68% |
| Jul 19 | $8.66 | $9.35 | $10.10 | +0.79% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.66 | $9.35 | $10.10 | +0.79% |
| Week 2 | $8.46 | $9.43 | $10.51 | +1.59% |
| Week 3 | $8.32 | $9.50 | $10.85 | +2.40% |
| Week 4 | $8.22 | $9.58 | $11.17 | +3.21% |
| Week 5 | $8.13 | $9.65 | $11.46 | +4.03% |
| Week 6 | $8.06 | $9.73 | $11.74 | +4.86% |
| Week 7 | $8.01 | $9.81 | $12.01 | +5.69% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments.
The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through websites, mobile applications, phones, and text-based interactions by its licensed clinicians.
The company offers its products and services under the Teladoc and BetterHelp brands. It serves employers, health plans, hospitals and health systems, insurance companies, and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc.
and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in New York, New York.
Teladoc Health, Inc. (TDOC) is the asset, currently trading at $9.52 per share. It has a market cap of $1.72B and ranks 2172.
The current price reflects the market’s assessment, with a year-by-year forecast covering 2026 through 2050 indicating a path of rising averages and bullish momentum beyond a neutral start in 2026.
For 2026, the forecast shows an average price of $9.52 with a range from $4.47 to $14.31 and a neutral sentiment. From 2027 onward, the forecasts depict a bullish trajectory, with averages climbing to $13.48 in 2027, $20.84 by 2030, and up to $187.36 by 2050, accompanied by rising ROIs over time (e.g., 41.6% in 2027, 1868% by 2050). These figures provide a long-run view of potential upside alongside inherent uncertainty and volatility.
A major floor 45.3% below — a decisive break under it would weaken the trend.
The nearest floor, 25.3% below — buyers have tended to step in here.
Price is pressing into resistance (2.6% away) — a breakout level to watch.
A major ceiling 20.3% above — clearing it would confirm fresh momentum.
Key TDOC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TDOC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.27 | Buy | $9.19 | Buy |
| MA 10 | $9.02 | Buy | $8.95 | Buy |
| MA 20 | $8.33 | Buy | $8.48 | Buy |
| MA 50 | $7.43 | Buy | $7.61 | Buy |
| MA 100 | $6.38 | Buy | $7.04 | Buy |
| MA 200 | $6.85 | Buy | $7.04 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 68.38 | Neutral |
| Stoch RSI (14) | 56.28 | Neutral |
| CCI (20) | 91.32 | Neutral |
| Williams %R (14) | -12.37 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 20.68 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 87.63 | Sell |
| TRIX (15) | 1.01 | Buy |
| Awesome (5,34) | 1.45 | Buy |
| Ultimate (7,14,28) | 70.23 | Sell |
| Momentum (10) | 1.37 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 9.33 | Sell |
| ADX (14) | 32.09 | Buy |
| ATR (14) | 0.22 | Info |
The 30-day technical picture is bullish based on current readings. RSI14 is 80, suggesting strong upside momentum.
The stock trades above both the SMA50 of $7.23 and the SMA200 of $6.83, indicating constructive near-term technical setup. Support is noted at $6.57, with resistance at $9.52, underscoring a tight range near the current level. The 30-day range spans from $7.82 to $11.59, highlighting the recent price band in which the stock has fluctuated.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.47 | $9.28 | $13.97 | 0% | Neutral | |
| $10.51 | $13.28 | $17.78 | +43% | Bullish | |
| $11.80 | $15.36 | $21.38 | +66% | Bullish | |
| $14.35 | $19.14 | $27.48 | +106% | Bullish | |
| $15.20 | $20.73 | $30.52 | +123% | Bullish | |
| $17.13 | $23.84 | $35.88 | +157% | Bullish | |
| $22.48 | $31.85 | $48.92 | +243% | Bullish | |
| $26.39 | $38.07 | $59.52 | +310% | Bullish | |
| $30.99 | $45.44 | $72.25 | +390% | Bullish | |
| $33.29 | $49.61 | $80.09 | +435% | Bullish | |
| $56.74 | $90.91 | $156.52 | +880% | Bullish | |
| $104.38 | $189.65 | $358.54 | +19.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.47 | $9.28 | $11.47 | +0.00% |
| August 2026 | $8.59 | $10.16 | $12.34 | +9.44% |
| September 2026 | $8.64 | $10.29 | $12.65 | +1.29% |
| October 2026 | $8.70 | $10.43 | $12.95 | +1.40% |
| November 2026 | $9.04 | $10.89 | $13.64 | +4.42% |
| December 2026 | $9.14 | $11.07 | $13.97 | +1.68% |
Click any year to see its month-by-month TDOC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Teladoc Health, Inc.'s 2026 outlook centres on $9.28, within a $4.47 to $13.97 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, TDOC could reach as high as $17.78, with a base case around $13.28 and support toward $10.51 — roughly +43% from $9.28. Momentum favours further upside here.
Expect TDOC to range from $11.80 to $21.38 through 2028. The $15.36 average target implies a +66% move from current prices. That is up +16% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The TDOC price prediction for 2029 points to an average of $19.14 (low $14.35, high $27.48) — a potential gain of +106% on today's $9.28. Momentum favours further upside here.
In 2030, TDOC is projected to trade between $15.20 and $30.52, averaging $20.73 — a potential gain of +123% from today's $9.28. That is up +8% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Teladoc Health, Inc.'s 2031 outlook centres on $23.84, within a $17.13 to $35.88 range. That is up +15% on the projected 2030 average. That marks a +157% change versus current levels. Momentum favours further upside here.
By 2032, TDOC could reach as high as $48.92, with a base case around $31.85 and support toward $22.48 — roughly +243% from $9.28. Buyers look set to stay in control over this stretch.
Expect TDOC to range from $26.39 to $59.52 through 2033. The $38.07 average target implies a +310% move from current prices. That is up +20% on the projected 2032 average. Momentum favours further upside here.
The TDOC price prediction for 2034 points to an average of $45.44 (low $30.99, high $72.25) — a potential gain of +390% on today's $9.28. Buyers look set to stay in control over this stretch.
In 2035, TDOC is projected to trade between $33.29 and $80.09, averaging $49.61 — a potential gain of +435% from today's $9.28. That is up +9% on the projected 2034 average. Momentum favours further upside here.
Teladoc Health, Inc.'s 2040 outlook centres on $90.91, within a $56.74 to $156.52 range. That is up +83% on the projected 2035 average. That marks a +880% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, TDOC could reach as high as $358.54, with a base case around $189.65 and support toward $104.38 — roughly +19.4x from $9.28. Momentum favours further upside here.
Investing $1,000 in TDOC today (≈ 107.758621 TDOC) could be worth
$20,436.63
+$19,436.63 (+1944%) by 2050 · US Dollar
Based on the average projected TDOC price of $189.65 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TDOCwould be worth at today's price.
$1,000 invested in TDOC on Jul 10, 2025 (≈ 113.507373 TDOC) would be worth
$1,053.35
+$53.35 (+5.3%) today · 1.05× · US Dollar
Based on a TDOC entry price of $8.81 vs. today's $9.28.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.2 | $1,008.7 | +0.9% |
| 1 month ago | $7.03 | $1,320.06 | +32.0% |
| 3 months ago | $5.1 | $1,819.61 | +82.0% |
| 6 months ago | $7.25 | $1,280 | +28.0% |
| 1 year ago | $8.81 | $1,053.35 | +5.3% |
| All time (5.0y) ago | $154.21 | $60.18 | -94.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TDOC forecast.
Our base-case forecast reaches $19.00 around 2029.
Implied market cap at $19.00: $3.43B
The multi-year forecast presents a bullish trajectory from 2027 through 2050, with 2026 labeled as neutral. In 2027 the average price is $13.48 with a 41.6% ROI, followed by 2028 at $15.60 (63.9% ROI) and 2029 at $19.27 (102.5% ROI). By 2030 the average is $20.84 with a 118.9% ROI, and by 2031 it reaches $24.15 (153.6% ROI).
The 2032 forecast places the average at $32.42 (240.5% ROI), and 2033 at $38.59 (305.4% ROI). The path continues higher, with 2034 at $45.83 (381.4% ROI) and 2035 at $49.58 (420.8% ROI).
Longer-term horizons show substantial upside: 2040 average $92.07 (867.1% ROI) and 2050 average $187.36 (1868% ROI). Sentiment is bullish for these later years. Note that the forecast also indicates high volatility, with annualized volatility at 60%, underscoring the risk and uncertainty inherent in long-horizon projections.
Tap a question to reveal the answer.
Average forecast price for 2030 is $20.84, with a min of $15.19 and a max of $30.89; sentiment is bullish.
Forecasts show bullish sentiment from 2027 onward with rising averages and ROI, though 2026 is neutral. Demonstrated ROIs include 41.6% in 2027 and up to 1868% by 2050, recognizing the estimates are not guarantees.
Yes. The 2032 maximum forecast is $50.18, indicating the potential to exceed $50 in that year.
Current price is $9.52 and market cap is $1.72B.
RSI(14) is 80, indicating bullish momentum. SMA50 is $7.23 and SMA200 is $6.83, with support at $6.57 and resistance at $9.52. The 30-day range is $7.82 to $11.59.
Teladoc Health, Inc. Community Discussion
0Share your Teladoc Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.